Medical News

RSS

AMGA issues comments on CMS Request for Information on ACOs

The American Medical Group Association (AMGA), a trade association representing multispecialty medical groups and other organized systems of care, today released its comments on the CMS Request for Information on Accountable Care Organizations (ACOs). The comments were due and submitted on December 3, 2010. CMS has announced that the notice of proposed rulemaking on ACOs will be published early next year

10 Dec 2010

Accovion establishes two additional subsidiaries in the Czech Republic and in Russia

Accovion is a premier full service European CRO known for its expertise in managing and conducting international clinical trials. Accovion supports local and global projects of all types and phases for the pharmaceutical, biotechnology and medical device industries. Its services include study planning and management, clinical monitoring, pharmacovigilance including post-marketing safety, data management, biostatistics, statistical programming, medical writing and electronic publishing.

10 Dec 2010

Incoming House Foreign Affairs Committee chair outlines views on U.S. foreign policy; House passes FY 2011 funding act

Rep. Ileana Ros-Lehtinen (R-Fla.) "moved rapidly Wednesday to put her mark on U.S. foreign policy as the incoming chairman of the House Foreign Affairs Committee," McClatchy reports (Clark, 12/8).

10 Dec 2010

Harvard Bioscience files two major patents in regenerative medicine

Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.

From Harvard Bioscience 10 Dec 2010

FDA grants Neoprobe Type B pre-IND meeting for RIGS technology BLA

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.

10 Dec 2010

First genetic test on developing risk of Alzheimer's disease and heart attacks

Alzheimer and heart attacks have been found to share common genetic basis. The research leads the way to the first genetic test on developing the risk of the diseases even at a young age. According to Federico Licastro, an immunologist at the University of Bologna who coordinated the study published in the scientific journal, Journal of Alzheimer's Disease, a test is now ready. "They are already selling it in America", he says, citing the case of a private firm in New Mexico (USA) that collaborated on the study. "But the tests could easily be also conducted wherever, using a simple blood test".

10 Dec 2010

Depression treatment may help obese women to lose weight

The new study, which appears in the November/December issue of the journal General Hospital Psychiatry, cites past surveys that show having a body mass index (BMI) of 30 or more — classified as obese — increases a person's risk of depression by 50 percent to 150 percent.

10 Dec 2010

Prometheus, UCLA collaborate to identify biological markers of mucosal healing in IBD

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and The Regents of the University of California, Los Angeles campus, today announced the execution of an exclusive research agreement that will focus on the identification of biological markers of mucosal healing in patients with Inflammatory Bowel Disease (IBD). The research will be led by Dr. Jonathan Braun, Chair of the Department of Pathology and Laboratory Medicine and a professor of molecular and medical pharmacology, UCLA David Geffen School of Medicine.

10 Dec 2010

Simple molecular sensor color test to determine safe fluoride levels

Used in the proper amounts, it can make teeth stronger and aid in the treatment of osteoporosis. When excessive amounts are consumed, however, it can be a killer - a carcinogen that causes bone, lung and bladder cancers. The "it" is fluoride, a common additive in most American communities' drinking water and an ingredient in the vast majority of commercially produced adult toothpastes.

10 Dec 2010

WFP, UNAIDS work to improve nutritional support available for people living with HIV/AIDS

The World Program Program (WFP), with the support of UNAIDS, is planning to launch "a new policy to make food and nutritional support more available to people living with HIV," VOA News reports. The agency "says the aim of [the] program is to help patients stick to their treatment, while protecting their households from further vulnerability," the news service adds.

10 Dec 2010

Entinostat plus erlotinib improves survival in NSCLC patients with elevated E-cadherin

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).

10 Dec 2010

GeoVax's phase 2a trial results indicate excellent safety profile for HIV vaccine

GeoVax Labs, Inc., announced today that early results from part A of an ongoing phase 2a clinical trial indicate an excellent safety profile and highly reproducible immunogenicity.

10 Dec 2010

Fibrin microthreads support mesenchymal stem cell growth

A research team at Worcester Polytechnic Institute has demonstrated the feasibility of a novel technology that a surgeon could use to deliver stem cells to targeted areas of the body to repair diseased or damaged tissue, including cardiac muscle damaged by a heart attack. The technique involves bundling biopolymer microthreads into biological sutures and seeding the sutures with stem cells. The team has shown that the adult bone-marrow-derived stem cells will multiply while attached to the threads and retain their ability to differentiate and grow into other cell types.

10 Dec 2010

Blocking growth of blood vessels with antibodies could improve treatment of cancerous tumors

A novel strategy of blocking the growth of blood vessels with antibodies should result in improved treatment of cancerous tumors.

10 Dec 2010

Ambry Genetics announces launch of Illumina HiSeq 2000 Next Generation Sequencing Services

Ambry Genetics, a global leader in genomic services to the healthcare and life sciences industries, announced today that it has officially launched their Illumina HiSeq 2000 Next Generation Sequencing Services. Ambry Genetics has been an early adapter of Illumina sequencing systems since 2007 and has extensive experience as a Certified Service Provider.

10 Dec 2010

People exposed to North Dakota road materials face increase risk of developing mesothelioma

New data shows that people exposed to the mineral erionite found in the gravel of road materials in North Dakota may be at significantly increased risk of developing mesothelioma, a type of lung cancer most often associated with asbestos exposure, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology.

10 Dec 2010

Horizon Discovery licenses new human isogenic cell models from Case Western Reserve

With the goal of developing new, more effective and personalized cancer treatments, Horizon Discovery, based in Cambridge, England, has secured from Case Western Reserve University exclusive rights to a panel of new human isogenic cell models developed by the laboratory of Zhenghe Wang, assistant professor of genetics at the university's School of Medicine.

10 Dec 2010

Three-day meeting on eliminating river blindness kicks off in Nigeria

A three-day meeting of the WHO African Program for Onchocerciasis (River blindness) Control (WHO/APOC) opened in Abuja, Nigeria, on Tuesday, PANA/Afrique en ligne reports (12/8).

10 Dec 2010

Nuss Procedure safe and effective for chest deformity

Since 1987, when a surgeon at Children's Hospital of The King's Daughters developed a minimally-invasive surgery to correct sunken chest, the procedure has been adopted world-wide as a standard of care and continually refined to increase its effectiveness and safety, according to a paper published in the December issue of the Annals of Surgery.

10 Dec 2010

Celulas Genetica to submit international patent application for Rutherford Procedure

Emerging Healthcare Solutions, Inc. announced today that its newly acquired biotechnology division Celulas Genetica will submit an international patent application for the Rutherford Procedure, a revolutionary new stem-cell treatment for liver disease.

10 Dec 2010

Medical News

AMGA issues comments on CMS Request for Information on ACOs

Accovion establishes two additional subsidiaries in the Czech Republic and in Russia

Incoming House Foreign Affairs Committee chair outlines views on U.S. foreign policy; House passes FY 2011 funding act

Harvard Bioscience files two major patents in regenerative medicine

FDA grants Neoprobe Type B pre-IND meeting for RIGS technology BLA

First genetic test on developing risk of Alzheimer's disease and heart attacks

Depression treatment may help obese women to lose weight

Prometheus, UCLA collaborate to identify biological markers of mucosal healing in IBD

Simple molecular sensor color test to determine safe fluoride levels

WFP, UNAIDS work to improve nutritional support available for people living with HIV/AIDS

Entinostat plus erlotinib improves survival in NSCLC patients with elevated E-cadherin

GeoVax's phase 2a trial results indicate excellent safety profile for HIV vaccine

Fibrin microthreads support mesenchymal stem cell growth

Blocking growth of blood vessels with antibodies could improve treatment of cancerous tumors

Ambry Genetics announces launch of Illumina HiSeq 2000 Next Generation Sequencing Services

People exposed to North Dakota road materials face increase risk of developing mesothelioma

Horizon Discovery licenses new human isogenic cell models from Case Western Reserve

Three-day meeting on eliminating river blindness kicks off in Nigeria

Nuss Procedure safe and effective for chest deformity

Celulas Genetica to submit international patent application for Rutherford Procedure

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News